Does high mean platelet volume reflect platelet activation linked to inflammation and oxidative stress?

Mean Platelet Volume (MPV) is a standard laboratory measure of platelet size that serves as a highly sensitive indicator of platelet function and systemic pathology.

Mechanistic pathways of platelet activation

• Granule density and hyperactivity: Larger, younger platelets characterized by high MPV contain a higher density of alpha- and dense-granules. This structural shift leads to enhanced thromboxane synthesis, greater enzymatic activity, and a highly reactive aggregation phenotype.
• Leukocyte recruitment: Upon activation, platelets translocate P-selectin from intracellular alpha-granules to the cell surface. Surface P-selectin binds directly to P-selectin glycoprotein ligand-1 (PSGL-1) on leukocytes, forming platelet-leukocyte aggregates that release pro-inflammatory cytokines.
• TPO-driven feedback loop: Systemic inflammation stimulates thrombopoietin (TPO) signaling in the bone marrow. Elevated TPO alters megakaryopoiesis and accelerates the release of larger, hyperactive platelets into circulation, driving a continuous feed-forward loop.

Interactions with oxidative stress

• Nitric oxide depletion: Activated platelets generate high levels of intracellular reactive oxygen species (ROS), which consume and reduce the bioavailability of protective endothelial nitric oxide.
• Reciprocal activation: Elevated systemic oxidative stress and circulating inflammatory cytokines act directly on megakaryocytes to promote rapid, ROS-dependent differentiation, which further increases the production and circulation of high-MPV platelets.

Bottom line

• An elevated Mean Platelet Volume is a reliable biomarker of platelet hyperactivity, reflecting a self-sustaining cycle of thrombo-inflammation and oxidative stress that is highly relevant for assessing cardiovascular and inflammatory risk.